Hepato Cellular Carcinoma: Clinical Trials

2 trials for Hepato Cellular Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Not yet recruiting 1

Follow Hepato Cellular Carcinoma: new trials by email Literature Review of Hepato Cellular Carcinoma trials Research Report on Hepato Cellular Carcinoma

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery
Ebastine - Hepato Cellular Carcinoma
Phase 4Not yet recruitingSecond Affiliated Hospital of Xi'an Jiaotong University452026-10-012026-07-29
Kinectics of Distribution of Doxorubicin-Lipiodol Emulsion in c-TACE
Super selective transarterial chemoembolization of CHC, with doxorubicin reconstituted in 5cc iso-osmolar ionic iodinated contrast media, Super selective transarterial chemoembolization of CHC, with doxorubicin reconstituted in 5cc normal saline - Hepato Cellular Carcinoma
Phase 4CompletedUniversity Hospital, Strasbourg, France102018-11-262026-06-05

Interventions

ebastine (1)

Sponsors

Second Affiliated Hospital of Xi'an Jiaotong University (1)  ·  University Hospital, Strasbourg, France (1)

Countries

France (1)

NIH funding

2018 (1)